Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

GeneDx Holdings (WGS) EBIAT (2020 - 2025)

Historic EBIAT for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to -$7.6 million.

  • GeneDx Holdings' EBIAT rose 814.49% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 10249.47%. This contributed to the annual value of -$52.3 million for FY2024, which is 7025.27% up from last year.
  • As of Q3 2025, GeneDx Holdings' EBIAT stood at -$7.6 million, which was up 814.49% from $10.8 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' EBIAT ranged from a high of $32.7 million in Q3 2021 and a low of -$308.8 million during Q4 2022
  • Moreover, its 5-year median value for EBIAT was -$40.2 million (2021), whereas its average is -$54.0 million.
  • Per our database at Business Quant, GeneDx Holdings' EBIAT skyrocketed by 15781.33% in 2021 and then plummeted by 66834.89% in 2022.
  • Over the past 5 years, GeneDx Holdings' EBIAT (Quarter) stood at -$40.2 million in 2021, then tumbled by 668.35% to -$308.8 million in 2022, then soared by 91.65% to -$25.8 million in 2023, then surged by 121.1% to $5.4 million in 2024, then tumbled by 240.4% to -$7.6 million in 2025.
  • Its EBIAT stands at -$7.6 million for Q3 2025, versus $10.8 million for Q2 2025 and -$6.5 million for Q1 2025.